These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis. Ashokkumar P; Sudhandiran G Biomed Pharmacother; 2008 Nov; 62(9):590-7. PubMed ID: 18692983 [TBL] [Abstract][Full Text] [Related]
3. Effect of luteolin on the levels of glycoproteins during azoxymethane-induced colon carcinogenesis in mice. Pandurangan AK; Dharmalingam P; Ananda Sadagopan SK; Ganapasam S Asian Pac J Cancer Prev; 2012; 13(4):1569-73. PubMed ID: 22799368 [TBL] [Abstract][Full Text] [Related]
4. Luteolin inhibits cell proliferation during Azoxymethane-induced experimental colon carcinogenesis via Wnt/ β-catenin pathway. Ashokkumar P; Sudhandiran G Invest New Drugs; 2011 Apr; 29(2):273-84. PubMed ID: 20013030 [TBL] [Abstract][Full Text] [Related]
5. Luteolin, a bioflavonoid, attenuates azoxymethane-induced effects on mitochondrial enzymes in BALB/c mice. Pandurangan AK; Ananda Sadagopan SK; Dharmalingam P; Ganapasam S Asian Pac J Cancer Prev; 2014 Jan; 14(11):6669-72. PubMed ID: 24377586 [TBL] [Abstract][Full Text] [Related]
6. Optical imaging of MMP expression and cancer progression in an inflammation-induced colon cancer model. Lee CM; Jang D; Cheong SJ; Jeong MH; Kim EM; Kim DW; Lim ST; Sohn MH; Jeong HJ Int J Cancer; 2012 Oct; 131(8):1846-53. PubMed ID: 22287125 [TBL] [Abstract][Full Text] [Related]
7. Soybean saponin inhibits tumor cell metastasis by modulating expressions of MMP-2, MMP-9 and TIMP- 2. Kang JH; Han IH; Sung MK; Yoo H; Kim YG; Kim JS; Kawada T; Yu R Cancer Lett; 2008 Mar; 261(1):84-92. PubMed ID: 18086515 [TBL] [Abstract][Full Text] [Related]
8. Luteolin, a bioflavonoid inhibits azoxymethane-induced colon carcinogenesis: Involvement of iNOS and COX-2. Pandurangan AK; Kumar SA; Dharmalingam P; Ganapasam S Pharmacogn Mag; 2014 Apr; 10(Suppl 2):S306-10. PubMed ID: 24991108 [TBL] [Abstract][Full Text] [Related]
9. Luteolin inhibits proliferation and induces apoptosis of human melanoma cells in vivo and in vitro by suppressing MMP-2 and MMP-9 through the PI3K/AKT pathway. Yao X; Jiang W; Yu D; Yan Z Food Funct; 2019 Feb; 10(2):703-712. PubMed ID: 30663726 [TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer]. Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459 [TBL] [Abstract][Full Text] [Related]
11. Luteolin, a bioflavonoid inhibits Azoxymethane-induced colorectal cancer through activation of Nrf2 signaling. Pandurangan AK; Ananda Sadagopan SK; Dharmalingam P; Ganapasam S Toxicol Mech Methods; 2014 Jan; 24(1):13-20. PubMed ID: 24024667 [TBL] [Abstract][Full Text] [Related]
12. [The role of disequilibrium of expression of matrix metalloproteinase-2/9 and their tissue inhibitors in pathogenesis of hyperoxia-induced acute lung injury in mice]. Zhang XF; Zhu GF; Liu S; Foda HD Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Oct; 20(10):597-600. PubMed ID: 18926070 [TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis. Tanaka T; Kojima T; Suzui M; Mori H Cancer Res; 1993 Sep; 53(17):3908-13. PubMed ID: 8358716 [TBL] [Abstract][Full Text] [Related]
14. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane. Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579 [TBL] [Abstract][Full Text] [Related]
15. MT1-MMP and TIMP-2 are first expressed in the colon glands after a single dose of azoxymethane (AOM). da Silva J; Freitas JR; do Carmo ER; Gomes JR Anat Rec (Hoboken); 2024 Jun; 307(6):2187-2196. PubMed ID: 37966140 [TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells. Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464 [TBL] [Abstract][Full Text] [Related]
17. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats. Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983 [TBL] [Abstract][Full Text] [Related]
18. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer. Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471 [TBL] [Abstract][Full Text] [Related]
19. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas]. Wei QY; Wu YQ; Fan SQ Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069 [TBL] [Abstract][Full Text] [Related]